Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Inflammatory Bowel Disease
24. November 2025
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2786
Articles 1 - 20 / 55710
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.
Gastroenterology
Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S.
PMID: 41274746 [PubMed - indexed for MEDLINE]
Structure-activity relationships of sulfated polysaccharides in inflammatory bowel disease: Sources, mechanisms, and therapeutic potential.
Carbohydr Polym
Liu W, Shen M, Li J, Xie J.
PMID: 41274736 [PubMed - indexed for MEDLINE]
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.
Inflamm Bowel Dis
Faye AS, Rubin DT, Siegel CA, Long MD, Khan N, Danese S, Irving PM, Cross RK, Blumenstein I, Armuzzi A, Horst SN, Dignass A, Kobayashi T, Lawlor G, Krakovich A, Petersen A, Liu Z, Wang D, Jain A, Ananthakrishnan AN, Sabino J.
PMID: 41274280 [PubMed - as supplied by publisher]
Extended mesenteric resection in Crohn's disease: EXCEED Study Protocol-a blinded multicenter randomized controlled clinical trial (RCT).
Trials
Bælum JK, Rosenberg J, Larsen P, Joergensen M, De La Croix H, Haglind E, Agenete E, BEAT-IBD research group.
PMID: 41272703 [PubMed - indexed for MEDLINE]
Identifying key clinical and biochemical predictors of treatment outcomes in inflammatory bowel disease: a real-world evidence study.
Sci Rep
Rodríguez JLG, Parrado CV, Cordero-Ramos J, Bouallou A, Armengol de la Hoz MÁ, Arias FA.
PMID: 41271947 [PubMed - indexed for MEDLINE]
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial.
Lancet Gastroenterol Hepatol
Kaplan JL, Bousvaros A, Turner D, Dubinsky M, Larkin A, Johns J, Otani Y, Crandall W, Komocsar WJ, Hyams JS.
PMID: 41270771 [PubMed - as supplied by publisher]
Extraintestinal malignancies in inflammatory bowel disease - deciphering hazardous relationships: A literature review.
Dent Med Probl
Gromny I, Aab A, Litwiniuk M, Neubauer K.
PMID: 41267664 [PubMed - indexed for MEDLINE]
Efficacy of Adalimumab Biosimilars in Managing Perianal Fistula in Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.
Clin Ter
Abdelrehim KMM, Elganyni AKE, Elagouz AEE, Elganyny MKE, Abdelaal RAA, Al Naoufi EF, Maskji HA, Bakry MR.
PMID: 41267606 [PubMed - indexed for MEDLINE]
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn's Disease.
Clin Gastroenterol Hepatol
Vuyyuru SK, Hanzel J, Brar MS, Danese S, D'Haens G, Faubion WA Jr, Feagan BG, Hart A, Kotze PG, Lee MJ, Panaccione R, Panes J, Peyrin-Biroulet L, Rimola J, Sands BE, Santillan CS, Segal JP, Stoker J, Taylor SA, Archer S, Kiarasi S, Shackelton LM, Jairath V, Ma C.
PMID: 41265547 [PubMed - as supplied by publisher]
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease.
J Crohns Colitis
Vermeire S, Colombel JF, Danese S, Panaccione R, Peyrin-Biroulet L, Beck K, Chaparro M, Gisbert JP, Dubcenco E, Klaff J, Naling G, Ford S, Remple V, Joshi N, Suravaram S, Duncan B, Wang Y, Wick-Urban B, Loftus EV Jr.
PMID: 41264726 [PubMed - as supplied by publisher]
A multilayered genetic structure analysis between inflammatory bowel disease and bone density/osteoporosis.
PLoS One
Qin M, Liu X, Luo Q, Cai R.
PMID: 41264632 [PubMed - indexed for MEDLINE]
Measuring Fatigue and Heart Rate Variability Using A Wearable Patch in Ulcerative Colitis Patients: A Cross-Sectional Pilot Study.
J Clin Gastroenterol
Metselaar PI, van der Hoff MJ, van den Broek TJ, Kamstra RJM, Uzunbajakava NE, Welting O, van den Brink WJ, Te Velde AA, Löwenberg M.
PMID: 41264336 [PubMed - as supplied by publisher]
Tumor Development in Ulcerative Colitis: Perspectives From Biomechanical Characteristics.
Dev Growth Differ
Tao H.
PMID: 41263591 [PubMed - as supplied by publisher]
Post-operative Outcomes Following Urgent and Elective Surgery for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Cureus
Sarkar S, Latheesh R.
PMID: 41262487 [PubMed]
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trial.
Contemp Clin Trials
Keefer L, Ungaro R, Lewis A, Lee J, de Amorrortu C, Lores T, Siganporia T, Mehandru S, Petralia F, Colombel JF.
PMID: 41260461 [PubMed - as supplied by publisher]
Exploring Gut Mucosal Microbiota to Distinguish Crohn's Disease from Intestinal Tuberculosis.
Inflamm Bowel Dis
Kuriakose AC, Abraham D, Benny B, Govindan K, Kurien RT, Chowdhury SD, Simon EG, Pulimood A, Joseph AJ, Dutta AK.
PMID: 41259209 [PubMed - as supplied by publisher]
Serum Protein Profiles Differ with Adalimumab and Ustekinumab Treatment in Moderately to Severely Active Crohn's Disease.
J Crohns Colitis
Venkat S, Zeeman M, Hart A, Bhagat S, Galbraith DA, Hoops T, Ufberg PJ, Izanec J, Freeman TC, Mcrae B, Shinzaki S, Jairath V, Panaccione R, Sands BE, Branigan P.
PMID: 41258994 [PubMed - as supplied by publisher]
Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: A randomized, multicentre, open-label study by GETECCU.
J Crohns Colitis
Llaó J, Mañosa M, Martín-Arranz E, Zabana Y, Navarro-Llavat M, Téller M, Garcia-Planella E, Busquets D, Monfort D, Pineda JR, Gutiérrez A, Villoria A, Menchén L, Bastida G, García-Alonso FJ, Rivero M, Chaparro M, de Francisco R, Merino O, Rodríguez-Lago I, Barreiro-de Acosta M, Rodríguez-Fortúnez P, Rodríguez-Jiménez C, Calafat M, Domènech E, CECUM study group of the GETECCU.
PMID: 41258993 [PubMed - as supplied by publisher]
The diagnostic value of miR-340-5p in pediatric ulcerative colitis and its molecular mechanism by targeting MAP3K2 to modulate intestinal epithelial cell dysfunction.
Hereditas
Meng F, Han X, Ge L, Guan N.
PMID: 41257990 [PubMed - indexed for MEDLINE]
Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease.
World J Gastroenterol
Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P, Díaz-Suárez L, Carmona-Segovia AD, Becerra-Munoz VM, Jiménez-Navarro M, Arranz-Salas I, López-Villodres JA, Fernández-Castañer A, Gutiérrez-Martínez F, Rodríguez-González FJ, Camargo-Camero R, Alcaín-Martínez G, Rodríguez-Díaz C, García-Fuentes E, Sánchez-Quintero MJ, López-Gómez C.
PMID: 41257277 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 55710
Page 1 of 2786
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy